Randomized control trial on efficacy of transcatheter arterial chemoembolization with cisplatin-lipiodol suspension or epirubicin-lipiodol emulsion for hepatocellular carcinoma.
Phase 3
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000001153
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Okayama University Graguate School of Medicine, Dentistry and Pharmaceutical Sciences.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Not provided
Exclusion Criteria
1. Active double cancers. 2. Severe complications (excluding chronic hepatitis and liver cirrhosis). 3. Cardiomyopathy , congestive heart failure or medical history of them. 4. Total dose limiting of anticancer drugs with cardiac toxicity, ex. anthracyclin. 5. Medical history of severe hypersensitivity. 6. Pregnant, lactating women or women with suspected pregnancy. 7. Inappropriate patients for this study judged by the physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method